- 全部删除
- 您的购物车当前为空
Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) 是一种 Rabbit 抗体,靶向 West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III)。Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) 可用于 WB。
Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) 是一种 Rabbit 抗体,靶向 West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III)。Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) 可用于 WB。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
20 μL | ¥ 790 | 5日内发货 | |
100 μL | ¥ 2,480 | 5日内发货 |
产品描述 | Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) is a Rabbit antibody targeting West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III). Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E/Envelope (Domain III) Antibody (1U13) can be used in WB. |
Ig Type | Rabbit IgG |
克隆号 | 1U13 |
验证活性 | Anti-West Nile Virus (WNV) (lineage 1, strain NY99) E / Envelope rabbit monoclonal antibody at 1:1000 dilution. -Sample:West Nile Virus (WNV) (lineage 1, strain NY99) E / Envelope Recombinant Protein -Lane A: 20ng -Lane B: 5ng -Secondary -Goat Anti-Rabbit IgG (H+L)/HRP at 1/10000 dilution. -Developed using the ECL technique. -Performed under reducing conditions. |
应用 | WB |
推荐剂量 | WB: 1:1000-1:5000 |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant West Nile Virus (WNV) (lineage 1, strain NY99) E / Envelope Protein (Domain III) ( ABA62343.1Gln586-Ala705). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
偶联 | Unconjugated |
免疫原 | Recombinant Protein: West Nile Virus (WNV) (lineage 1, strain NY99) E / Envelope Protein (Domain III) Protein |
抗原种属 | WNV |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容